BAP31 (BCAP31) (NM_005745) Human Mass Spec Standard
Specifications
| Product Data | |
| Tag | C-Myc/DDK |
|---|---|
| Species | Human |
| Expression Host | HEK293 |
| Expression cDNA Clone or AA Sequence | RC204804 |
| Predicted MW | 28 kDa |
| Protein Sequence | |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Labeling Method | Labeled with U- 13C6, 15N4-L-Arginine and U- 13C6, 15N2-L-Lysine |
| Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
| Storage | Store at -80°C. Avoid repeated freeze-thaw cycles. |
| Stability | Stable for 3 months from receipt of products under proper storage and handling conditions. |
| Shipping | Dry Ice |
| Reference Data | |
| RefSeq | NP_005736 |
| RefSeq Size | 1417 |
| RefSeq ORF | 738 |
| Synonyms | 6C6-AG; BAP31; CDM; DDCH; DXS1357E |
| Locus ID | 10134 |
| UniProt ID | P51572 |
| Cytogenetics | Xq28 |
| Summary | This gene encodes a member of the B-cell receptor associated protein 31 superfamily. The encoded protein is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in caspase 8-mediated apoptosis. Microdeletions in this gene are associated with contiguous ABCD1/DXS1375E deletion syndrome (CADDS), a neonatal disorder. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome 16. provided by RefSeq, Jan 2012 |
| Protein Families | Druggable Genome, Transmembrane |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Other "BAP31" proteins (11)
| SKU | Description | Size | Price | |
|---|---|---|---|---|
| PH326633 | BCAP31 MS Standard C13 and N15-labeled recombinant protein (NP_001132913) | 10 ug |
$3,360.00
|
|
| PH327334 | BCAP31 MS Standard C13 and N15-labeled recombinant protein (NP_001132929) | 10 ug |
$3,360.00
|
|
| LC401750 | Lyophilized BCAP31 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC427957 | Lyophilized BCAP31 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC427962 | Lyophilized BCAP31 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LY401750 | Transient overexpression lysate of B-cell receptor-associated protein 31 (BCAP31), transcript variant 2 (as WB positive control) | 100 ug |
$436.00
|
|
| LY427957 | Transient overexpression lysate of B-cell receptor-associated protein 31 (BCAP31), transcript variant 3 (as WB positive control) | 100 ug |
$436.00
|
|
| LY427962 | Transient overexpression lysate of B-cell receptor-associated protein 31 (BCAP31), transcript variant 1 (as WB positive control) | 100 ug |
$436.00
|
|
| TP304804 | Recombinant protein of human B-cell receptor-associated protein 31 (BCAP31), transcript variant 2, 20 µg | 20 ug |
$737.00
|
|
| TP326633 | Recombinant protein of human B-cell receptor-associated protein 31 (BCAP31), transcript variant 3, 20 µg | 20 ug |
$737.00
|
|
| TP327334 | Recombinant protein of human B-cell receptor-associated protein 31 (BCAP31), transcript variant 1, 20 µg | 20 ug |
$737.00
|
|
Citations
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.